Methadone-induced Torsade de pointes after stopping lopinavir-ritonavir.
Lüthi
B
B
Department of Internal Medicine, Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, Raemistrasse 100/RAE U 74, 8091, Zurich, Switzerland.
Huttner
A
A
Speck
R F
RF
Mueller
N J
NJ
D000701:Analgesics, Opioid / Q000009:adverse effects*; D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D061466:Lopinavir; D008691:Methadone / Q000009:adverse effects*; D008875:Middle Aged; D011744:Pyrimidinones / Q000008:administration & dosage; D019438:Ritonavir / Q000008:administration & dosage; D016171:Torsades de Pointes / Q000139:chemically induced*
D000701:Analgesics, Opioid; D044966:Anti-Retroviral Agents; D004338:Drug Combinations; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir; D008691:Methadone